Candesartan CAS 139481-59-7 Tsaftace> 99.0% (HPLC) Factory
Ruifu Chemical Supply Candesartan Cilexetil Matsakaici Tare da Babban Tsafta
Candesartan Cilexetil CAS 145040-37-5
Candesartan CAS 139481-59-7
1-Chloroethyl Cyclohexyl Carbonate CAS 99464-83-2
Candesartan Cilexetil Intermediate Eethyl Ester C6 CAS 139481-41-7
Candesartan Cilexetil Matsakaici CAS 139481-44-0
Tril Candesartan Cilexetil CAS 170791-09-0
Sunan Sinadari | Candesartan |
Makamantu | CV-11974;2-Ethoxy-1-[[2'- (1H-tetrazol-5-yl) [1,1'-biphenyl] -4-yl] methyl] -1H-Benzimidazole-7-Carboxylic Acid;3-[[2'- (1H-Tetrazol-5-yl) biphenyl-4-yl] methyl] -2-ethoxy-3H-Benzimidazole-4-Carboxylic Acid;Candesartan M1;Candesartan Cilexetil EP Impurity G |
Lambar CAS | 139481-59-7 |
Lambar CAT | Saukewa: RF-PI1889 |
Matsayin Hannun jari | A cikin Hannun jari, Ma'aunin samarwa Har zuwa Ton |
Tsarin kwayoyin halitta | Saukewa: C24H20N6O3 |
Nauyin Kwayoyin Halitta | 440.45 |
Alamar | Ruifu Chemical |
Abu | Ƙayyadaddun bayanai |
Bayyanar | Farin Foda |
Identification-HPLC | Lokacin Riƙewa Yayi kama da Ma'auni |
Identification-IR | Kama da Standard |
Tsarkake / Hanyar Bincike | > 99.0% (HPLC) |
Matsayin narkewa | 183.0 ~ 185.0 ℃ |
Asara akan bushewa | <0.50% |
Danshi (KF) | <0.50% |
Ragowa akan Ignition | <0.50% |
Karfe masu nauyi | <20ppm |
Rashin Tsabtace Mutum | <1.00% (HPLC) |
Jimlar ƙazanta | <1.00% (HPLC) |
Fihirisar Refractive | n20/D 1.745~1.747 |
Matsayin Gwaji | Matsayin Kasuwanci |
Amfani | API;Domin Maganin Hawan Jini |
Kunshin: Bottle, Aluminum tsare jakar, 25kg / kwali Drum, ko bisa ga abokin ciniki ta bukata
Yanayin Ajiya:Ajiye a cikin kwantena da aka rufe a wuri mai sanyi da bushe;Kare daga haske da danshi
Candesartan (CAS: 139481-59-7) antagonist mai karɓar mai karɓar angiotensin II tare da IC50 na 0.26 nM.Manufa: Angiotensin II Receptor candesartan ana nuna shi don maganin hauhawar jini.Candesartan Cilexetil an fara amincewa da shi a cikin GB a ranar 29 ga Afrilu, 1997, sannan Hukumar Abinci da Magunguna ta Amurka (FDA) ta amince da ita a ranar 4 ga Yuni, 1998, kuma Hukumar Kula da Magunguna da Magunguna ta Japan (PMDA) ta amince da ita a ranar 12 ga Maris, 1999. AstraZeneca ne ya haɓaka shi, sannan aka tallata shi azaman Atacand ta AstraZeneca a GB da Amurka, kuma Takeda ya tallata shi azaman Blopress a cikin JP.Candesartan Cilexetil shine mai hana mai karɓa na angiotensin II (ARB), yana toshe tasirin vasoconstrictor da aldosterone na angiotensin II ta hanyar zaɓin toshe ɗaurin angiotensin II zuwa mai karɓar AT1 a cikin kyallen takarda da yawa, kamar tsoka mai santsi na jijiyoyin jini da glandar adrenal.Ana nuna Atacand don maganin hauhawar jini a cikin manya da yara 1 zuwa <17 shekaru, rashin ciwon zuciya (NYHA class II-IV) kuma ana amfani dashi don rage mutuwar zuciya da jijiyoyin jini da kuma rashin ciwon zuciya a asibiti.